SCHEMBL19655104

SCHEMBL19655104

c1ccc(-c2ccc3nc(-c4ccccc4)c(-n4c5ccccc5c5c6c7ccccc7n(-c7nc8cc(-c9ccccc9)ccc8nc7-c7ccccc7)c6ccc54)nc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 1/20 0.43
PIK3CA P42336 1/20 0.43
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
TLR9 Q9NR96 1/20 0.39
HSD17B10 Q99714 2/20 0.37
CASP1 P29466 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
GAA P10253 3/20 0.37
HPGD P15428 3/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DHODH Q02127 5/20 0.36
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19655093 1.00 PIK3R1 (0.43) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19653896 0.95 PIK3R1 (0.40) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19653886 0.95 PIK3R1 (0.40) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19653894 0.95 PIK3R1 (0.40) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19653895 0.95 PIK3R1 (0.40) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19655407 0.93 PIK3R1 (0.38) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19653900 0.93 PIK3R1 (0.38) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL19653899 0.93 PIK3R1 (0.38) PIK3R1PIK3CAKDM4EALDH1A1KMT2A
SCHEMBL20152135 0.92 HSD17B10 (0.43) KDM4EALDH1A1KMT2AL3MBTL1ATM
SCHEMBL22661779 0.89 PIK3R1 (0.36) PIK3R1PIK3CAKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 PIK3R1 4458/4885PIK3CA 4176/4885KDM4E 3377/4885
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDXK, MT-ND4L, PNPO PIK3R1 4321/4885PIK3CA 2364/4885KDM4E 2543/4885
US-10840458-B2 Organic electroluminescent materials and devices PDXK, MT-ND4L, PNPO PIK3R1 4321/4885PIK3CA 2364/4885KDM4E 2543/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 PIK3R1 4458/4885PIK3CA 4176/4885KDM4E 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.